TORONTO, Feb. 21, 2013 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial
manufacturing services to the global pharmaceutical industry, announced
today that it will report its fiscal 2013 first quarter financial
results on Friday, March 8, 2013.
In conjunction with the company's financial results announcement,
Patheon will host a conference call and webcast on Friday, March 8,
2013 at 10 a.m. Eastern Time. The financial results news release will
be issued at approximately 7 a.m. Eastern Time on Friday, March 8,
Interested parties are invited to access the conference call, via
telephone, in listen-only mode, toll-free at 1-888-231-8191 (U.S.,
including Puerto Rico) and 1-647-427-7450 (Canada and international).
Listeners are encouraged to dial in five to fifteen minutes in advance
to avoid delays. Slides will also be available for viewing during the
call by accessing http://ir.patheon.com/events.cfm.
A telephone replay of the conference call will be available between
Friday, March 8, 2013 and Friday, March 15, 2013 by dialing
1-855-859-2056 (toll-free) or 1-403-451-9481, and by entering
identification number 99069353, followed by the number key. The
webcast and slides will be archived at http://ir.patheon.com/events.cfm.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading provider of contract development
and commercial manufacturing services to the global pharmaceutical
industry for a full array of solid and sterile dosage forms. Through
the company's recent acquisition of Banner Pharmacaps - a market leader
in soft gelatin capsule technology - Patheon now also includes a
proprietary products and technology business.
Patheon provides the highest quality products and services to
approximately 300 of the world's leading pharmaceutical and
biotechnology companies. The company's integrated network consists of
18 locations, including 14 commercial contract manufacturing facilities
and 12 development centers across North America and Europe. Patheon
enables customer products to be launched with confidence anywhere in
the world. For more information visit www.patheon.com.
SOURCE: Patheon Inc.
For further information:
Senior Representative, Corporate Communications & Investor Relations
919 226 3200